Time to discuss: changes in the NICE NG28 guidance | GPnotebook TV

This site is intended for UK healthcare professionals

GPnotebook ↗︎
GPnotebook Podcast ↗︎
blank
×

Prescribing information for Jardiance (empagliflozin) for Great Britain and Northern Ireland.

This sponsored promotional content has been developed, organised, and funded by the Boehringer Ingelheim and Lilly Alliance and is intended for UK healthcare professionals only. Promotional information regarding Boehringer Ingelheim and Lilly Alliance products will be discussed. GPnotebook has had no input into the content.

Time to discuss: changes in the NICE NG28 guidance

29 November 2022

Sponsored

Dr Sarah Jarvis and Dr Yassir Javaid discuss the latest NICE updates (NG28, 2022) and highlight what NICE has changed in type 2 diabetes treatment and management.

Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone), or by e-mail: [email protected].

jar_logo_01
PC-GB-107546 | December 2022
Related videos

PC-GB-107597 | December 2022

blank

The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

© Oxbridge Solutions Ltd, 2023

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

blank

To continue, please confirm that you are a UK healthcare professional.

I am not a UK healthcare professional
I confirm I am a UK healthcare professional